Sayed C, Shi V, Hsiao J, Kokolakis G, Kirby B, Piguet V, Davis L, Bari M, Madden C, Knowles S, Prens E. Bimekizumab Efficacy by Prior Biologic Treatment in Patients with Moderate to Severe Hidradenitis Suppurativa: 48-Week Pooled Data from the Randomized, Double-Blind, Placebo-Controlled, Multicenter BE HEARD I and II Phase 3 Trials. J of Skin [Internet]. 2024 Jan. 16 [cited 2024 Jul. 3];8(1):s349. Available from: https://jofskin.org/33014/index.php/skin/article/view/2449